FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Medical Devices

CS Medical Ultrasound Probe Cleaner Cleared

FDA clears a CS Medical 510(k) for its Ethos Automated Ultrasound Probe Cleaner Disinfector.

latest-news-card-1
Human Drugs

Hold Lifted on Pharvaris Angioedema Drug

FDA lifts a Pharvaris clinical hold on a deucrictibant clinical trial for the on-demand treatment of hereditary angioedema attacks.

latest-news-card-1
Human Drugs

Pfizer Dumps Lotiglipron on Liver Injury Concerns

Citing potential liver injury concerns, Pfizer says it is terminating the development program for glucagon-like peptide-1 receptor agonist anti-diabet...

latest-news-card-1
Biologics

7-Year Echo: Marks Overrode Reviewers on Duchenne Therapy

CBER director Peter Marks overrides the review team in the 6/22 accelerated approval of Sarepta Therapeutics Duchenne muscular dystrophy gene therapy ...

latest-news-card-1
Human Drugs

Draft Guide on Medical Psychedelic Drugs

FDA posts a draft guidance entitled Psychedelic Drugs: Considerations for Clinical Investigations.

latest-news-card-1
FDA General

Senate FDA Appropriations Bill Includes $20 Million Increase

The Senate Appropriations Committee approves FDAs appropriations bill, which provides the agency a $20 million spending increase.

latest-news-card-1
Human Drugs

Intercept Hit With 2nd Denial on NASH Drug

FDA sends Intercept Pharmaceuticals a second complete response letter on its NDA resubmission for obeticholic acid for treating pre-cirrhotic fibrosis...

latest-news-card-1
FDA General

Guide on Cold-stored Platelets for Bleeding

FDA posts a final guidance entitled Alternative Procedures for the Manufacture of Cold-Stored Platelets Intended for the Treatment of Active Bleeding ...

latest-news-card-1
Federal Register

Guide on OTC Monograph Dispute Resolution

Federal Register notice: FDA releases a draft guidance entitled Formal Dispute Resolution and Administrative Hearings of Final Administrative Orders U...

latest-news-card-1
Human Drugs

Jazz Pharma Sues FDA Over Competitor Approval

Jazz Pharmaceuticals sues FDA and seeks the reversal of a 5/1 approval of Avadel CNS Pharmaceuticals Lumryz, a sodium oxybate drug product citing Jazz...